{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:44:22Z","timestamp":1791510262154,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002923","name":"National Scientific and Technical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007868","name":"SECyT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008056","name":"Florencio Fiorini Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.gene.2019.01.038","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T01:09:38Z","timestamp":1549760978000},"page":"71-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Single nucleotide polymorphism in PTEN-Long gene: A risk factor in chronic myeloid leukemia"],"prefix":"10.1016","volume":"694","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6846-2701","authenticated-orcid":false,"given":"C.","family":"Ferri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Weich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"De Brasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Bengi\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fundia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Larripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2019.01.038_bb0005","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.gene.2019.01.038_bb0010","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.leu.2403756","article-title":"Gender aspects in chronic myeloid leukemia: long-term results from randomized studies","volume":"19","author":"Berger","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.gene.2019.01.038_bb0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nature10275","article-title":"A continuum model for tumour suppression","volume":"476","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.gene.2019.01.038_bb0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/blood-2002-09-2896","article-title":"Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis","volume":"102","author":"Branford","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.gene.2019.01.038_bb0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"Carpten","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.gene.2019.01.038_bb0030","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/10428194.2012.718767","article-title":"Early detection and quantification of mutations in the tyrosine kinase domain of chimerical BCR\u2013ABL1 gene combining high-resolution melting analysis and mutant-allele specific quantitative polymerase chain reaction","volume":"54","author":"Ferri","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.gene.2019.01.038_bb0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bcmd.2013.09.002","article-title":"Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy","volume":"52","author":"Ferri","year":"2014","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.gene.2019.01.038_bb0040","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.gene.2019.01.038_bb0045","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","article-title":"High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia","volume":"114","author":"Gutierrez","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.gene.2019.01.038_bb0050","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1007\/s13277-014-1810-7","article-title":"Glutathione S-transferase gene polymorphisms and susceptibility to chronic myeloid leukemia","volume":"35","author":"He","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.gene.2019.01.038_bb0055","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/s41467-017-01198-9","article-title":"Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis","volume":"8","author":"Hieronymus","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2019.01.038_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00277-015-2314-2","article-title":"Epidemiology of chronic myeloid leukaemia: an update","volume":"94","author":"H\u00f6glund","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.gene.2019.01.038_bb0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1234907","article-title":"A secreted PTEN phosphatase that enters cells to alter signaling and survival","volume":"341","author":"Hopkins","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.gene.2019.01.038_bb0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tibs.2014.02.006","article-title":"PTEN function: the long and the short of it","volume":"39","author":"Hopkins","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.gene.2019.01.038_bb0075","article-title":"PTEN regulates BCRP\/ABCG2 and the side population through the PI3K\/Akt pathway in chronic myeloid leukemia","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2019.01.038_bb0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1568009615666150921141004","article-title":"New insights into the molecular resistance mechanisms of chronic myeloid leukemia","volume":"16","author":"Huang","year":"2016","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.gene.2019.01.038_bb0085","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/sj.leu.2404137","article-title":"The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib","volume":"20","author":"Khorashad","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.gene.2019.01.038_bb0090","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.18632\/oncotarget.5436","article-title":"The BIM deletion polymorphism: a paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia","volume":"7","author":"Ko","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2019.01.038_bb0095","first-page":"335","article-title":"Resistance to imatinib: mutations and beyond","volume":"vol. 47","author":"La Ros\u00e9e","year":"2010"},{"key":"10.1016\/j.gene.2019.01.038_bb0100","first-page":"2124","article-title":"TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor \u03b2","volume":"57","author":"Li","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2019.01.038_bb0105","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.cmet.2014.03.023","article-title":"PTEN\u03b1, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism","volume":"19","author":"Liang","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.gene.2019.01.038_bb0110","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1039\/c3mb70267g","article-title":"The PTEN Long N-tail is intrinsically disordered: increased viability for PTEN therapy","volume":"9","author":"Malaney","year":"2013","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.gene.2019.01.038_bb0115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.molcel.2017.09.024","article-title":"PTEN regulates PI(3,4)P2 signaling downstream of class I PI3K","volume":"68","author":"Malek","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.gene.2019.01.038_bb0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/07357907.2015.1065499","article-title":"BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival","volume":"33","author":"Pagnano","year":"2015","journal-title":"Cancer Investig."},{"key":"10.1016\/j.gene.2019.01.038_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110682","article-title":"BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia","volume":"9","author":"Panuzzo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2019.01.038_bb0130","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3324\/haematol.2009.013797","article-title":"Role of the PI3K\/AKT and mTOR signalling pathways in acute myeloid leukemia","volume":"95","author":"Park","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.gene.2019.01.038_bb0135","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2009-06-228130","article-title":"PTEN is a tumor suppressor in CML stem cells and BCR-ABL\u2013induced leukemias in mice","volume":"115","author":"Peng","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.gene.2019.01.038_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2015.02.009","article-title":"PTEN: a yin-yang master regulator protein in health and disease","volume":"77","author":"Pulido","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.gene.2019.01.038_bb0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/107327480901600204","article-title":"Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia","volume":"16","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Cancer Control"},{"key":"10.1016\/j.gene.2019.01.038_bb0150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12032-017-0958-6","article-title":"Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors","volume":"34","author":"Rychter","year":"2017","journal-title":"Med. Oncol."},{"key":"10.1016\/j.gene.2019.01.038_bb0155","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1080\/10428194.2017.1312377","article-title":"Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome","volume":"58","author":"Shanmuganathan","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.gene.2019.01.038_bb0160","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1101\/gad.1724708","article-title":"Meeting DNA palindromes head-to-head","volume":"22","author":"Smith","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.gene.2019.01.038_bb0165","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: a web tool for the analysis of association studies","volume":"22","author":"Sole","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.gene.2019.01.038_bb0170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.clml.2015.02.035","article-title":"Mutations in the BCR-ABL1 kinase domain and elsewhere in chronic myeloid leukemia","volume":"15","author":"Soverini","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.gene.2019.01.038_bb0175","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1038\/onc.2015.462","article-title":"Oncogenic PTEN functions and models in T-cell malignancies","volume":"35","author":"Tesio","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2019.01.038_bb0180","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00432-011-1103-0","article-title":"Roles of genetic variants in the PI3K and RAS\/RAF pathways in susceptibility to endometrial cancer and clinical outcomes","volume":"138","author":"Wang","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.gene.2019.01.038_bb0185","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12072-015-9648-7","article-title":"Association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function","volume":"9","author":"Wang","year":"2015","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.gene.2019.01.038_bb0190","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/jhg.2011.48","article-title":"Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility","volume":"56","author":"Xie","year":"2011","journal-title":"J. Hum. Genet."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919300976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919300976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T16:40:27Z","timestamp":1565196027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111919300976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":38,"alternative-id":["S0378111919300976"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2019.01.038","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single nucleotide polymorphism in PTEN-Long gene: A risk factor in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2019.01.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}